Diehl, J.-L.
Piquilloud, L.
Vimpere, D.
Aissaoui, N.
Guerot, E.
Augy, J. L.
Pierrot, M.
Hourton, D.
Arnoux, A.
Richard, C.
Mancebo, J.
Mercat, A.
Article History
Received: 7 February 2020
Accepted: 18 September 2020
First Online: 29 September 2020
Ethics approval and consent to participate
: An institutional ethic board (Comité de Protection des Personnes Ile-de-France VI, Paris, France) approved the protocol (protocole EPHEBE P141 203-ID CRB: 2015-A100446-43). Informed consent was obtained from patients' legal representatives.
: Not applicable.
: Dr. Diehl reports grants and non-financial support from Alung, non-financial support from General Electric Healthcare, during the conduct of the study; personal fees and non-financial support from Xenios Novalung (Fresenius Medical Care) outside the submitted work.Dr. Aissaoui reports non-financial support from ASTRAZENECA, non-financial support from MEDTRONIC, non-financial support from ABIOMED, outside the submitted work.Dr. Mercat reports personal fees from Faron Pharmaceuticals, personal fees from Air Liquide Medical Systems, grants and personal fees from Fisher and Paykel, personal fees from Medtronic, personal fees from Drager, non-financial support from General Electric, outside the submitted work.